Delivery Order SPE2DB20D3104-SPE2DB25FV5J6
Award Date
2/14/25
Potential Completion Date
2/18/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,451.81 firm fixed-price delivery order covers the supply of 4566878224 - DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to manage diabetes. The contract has an ultimate completion date of January 10, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $26,918.93 firm fixed-price delivery order is for the supply of 4567012423 DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used to treat type 2 diabetes. The award is not designated as a set-aside contract. The contract is associated with a larger Indefinite Delivery Contract (IDC) valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $68,023.23 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, which are pharmaceutical products used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,482.40 firm fixed-price delivery order is for the supply of 4,566,690,343 units of the 10 mg Dapagliflozin tablet, a medication used to treat diabetes. This contract does not have a set-aside designation, indicating open competition. The award is associated with AmerisourceBergen's existing $999,999,999...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,325.32 firm-fixed-price delivery order contract is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S. The award is not designated under any set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,006.48 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a drug used in the management of diabetes. The contract has an ultimate completion date of January 9, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $14,364.07, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4566584207 DAPAGLIFLOZIN 10 MG TABLET 30S, a pharmaceutical product used for diabetes management. The award is a delivery order issued under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,483.74 firm fixed-price delivery order covers the supply of 4566816870 - DAPAGLIFLOZIN 5 MG TABLET 30S, a prescription medication used to manage diabetes. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as...
This federal contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,773.51, is a Firm Fixed Price Delivery Order for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used in the management of diabetes. The contract is not designated as a set-aside award. It is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,204.31 firm fixed-price delivery order is for the supply of DAPAGLIFLOZIN 10 MG TABLET 30S, a medication used for diabetes management. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...